Pt. Prodia Stem Cell Indonesia
Clinical trials sponsored by Pt. Prodia Stem Cell Indonesia, explained in plain language.
-
Hair loss showdown: secretome vs. PRP – which injection wins?
Disease control Recruiting nowThis study tests whether a new treatment called secretome can regrow hair better than platelet-rich plasma (PRP) injections in people with male or female pattern baldness. About 40 adults aged 25-59 will receive either secretome or PRP injections into the scalp. The goal is to se…
Phase: PHASE1, PHASE2 • Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Disease control
Last updated May 17, 2026 08:53 UTC
-
Could stem cells be the key to saving lives from Sepsis-Induced lung failure?
Disease control Recruiting nowThis study tests whether adding umbilical cord stem cells to standard care can help people with severe lung injury (ARDS) caused by pneumonia-related sepsis recover faster and lower their risk of death. About 15 adults aged 40 and older will receive either standard treatment, ste…
Phase: PHASE1, PHASE2 • Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Disease control
Last updated May 17, 2026 08:52 UTC
-
Could a One-Time stem cell shot help damaged kidneys?
Disease control Recruiting nowThis early-stage study tests whether a single injection of stem cells from donated umbilical cord tissue can safely improve kidney function in adults with type 2 diabetes and moderate-to-severe kidney damage. Ten participants aged 40–65 will receive the injection directly into th…
Phase: PHASE1, PHASE2 • Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Disease control
Last updated May 01, 2026 15:57 UTC